PubMed

Navigating through regulatory frameworks for digital therapeutics and biomarkers.

PMID: 41067729 · 2025-10-09

C, i, n, j, a, , K, o, l, l, e, r, ;, , M, a, r, c, , B, l, a, n, c, h, a, r, d, ;, , T, h, o, m, a, s, , H, ü, g, l, e

학술지Health informatics journal

연도2025-10-09

PMID41067729

초록

Background: Digital health technologies are often subject to regulatory requirements. Regulatory auditing processes are complex but necessary to guarantee quality, efficacy and safety of patients. Evolvements such as digitalized clinical trials, and digital biomarkers require a constant adaption of regulatory frameworks. Objective: This review aims to provide an overview on current regulations and standards for digital therapeutics and digital biomarkers, from technical development to market acc

공식 출처

PubMed에서 보기 →

데이터는 PubMed / NCBI에서 제공됩니다. 전문과 최신 정보는 반드시 공식 기록을 확인하세요.